VVMC participates in life-changing medical research
Committed to staying on the cutting-edge of medical care, Verde Valley Medical Center is a proud participant in several medical research projects.
Working with the University of Oxford in England and Harvard and Duke Universities, VVMC is the first hospital in Arizona to participate in both the REVEAL and ACCELERATE studies.
These trials are aimed at increasing HDL (good) cholesterol and decreasing LDL (bad) cholesterol in patients. More than 40,000 people worldwide, including over 150 local patients to date, are taking the new drug or a placebo to determine its effectiveness.
"These new drugs have the potential to significantly change the way we treat high cholesterol," said Samuel Butman, M.D., interventional cardiologist and director of Medical Research at VVMC and the Heart & Vascular Center of Northern Arizona (HVCNA).
"The fact that such significant medical research is taking place in our community is a true testament to the commitment of VVMC and HVCNA to provide the most advanced healthcare to our patients."
To learn more about this medical research project and other research projects, contact Dr. Butman at 928-634-1331 or Alicia Bigelow, B.S.N., HVCNA Cardiovascular Research office, at 928-639-5306.